Biocon Appoints Dr. Christiane Hamacher as CEO of Biocon Biologics India Limited
Deepthi | Myequity news | Date : 01-03-2019 20:10:00 IST
Biocon Ltd, Asia's premier biopharmaceuticals company, announced today that Dr. Christiane Hamacher has been appointed as CEO of Biocon Biologics India Ltd. effective today.
Dr. Hamacher comes with more than 20 years of leadership experience in both strategic and operational roles across the value chain in global pharma, spanning Asia, Europe and the U.S. She has been with Roche, Basel, Switzerland since 2007 and prior to that spent 10 years at Schering AG, Berlin, Germany.
Ms Kiran Mazumdar-Shaw, Chairperson & Managing Director, Biocon, said: "I am delighted to welcome Christiane Hamacher as CEO of Biocon Biologics India Ltd. Christiane joins us at a critical inflexion point in the business as we build our stature in the large and growing opportunity for biosimilar biologics. I am confident that she will successfully lead the company to become a major global player in the near future. Being a woman leader, I believe she also brings a diversity perspective which is integral to our leadership journey."
Dr. Hamacher is an accomplished international C-suite executive with a passion for setting the corporate vision, defining and implementing future-driven strategy and growing businesses through entrepreneurial innovation and patient-centricity. She has robust experience in steering complex, global matrix organizations, quickly building strong, trusting relationships to enable achievement of top-level results.
During her long career in the pharmaceutical industry, she has built expertise in the areas of oncology, virology, CNS, cardiovascular, gynaecology, diagnostics, dermatology, rheumatology and rare diseases. She holds a Ph.D. in Molecular Biology (Oncology) from the University Clinic Bergmannsheil I University of Bochum, Germany. She also studied Economics at the University of Hagen, Germany.
Biocon Biologics India Ltd is a wholly-owned subsidiary of Biocon Ltd.
About Biocon Ltd:
Biocon Limited is a fully-integrated, innovation-led global biopharmaceutical company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and taken differentiated Small Molecules, Novel Biologics and a range of Biosimilars from 'Lab to Market' in India, key emerging and developed markets.